The news of RBC Capital maintaining an 'Outperform' rating on IBEX indicates a positive outlook for the company. However, the lowering of the price target from $30 to $27 may create some uncertainty among investors. This mixed sentiment is likely to result in a neutral short-term impact on IBEX's stock price.